Bill Ludwig, patient who helped pioneer cancer immunotherapy at Penn, dies at 75 of COVID-19 Marie McCullough, The Philadelphia Inquirer
Bill Ludwig was losing his decade-long battle with an insidious type of leukemia when he became the inaugural recipient of an experimental immune therapy being developed at the Hospital of the University of Pennsylvania.
“I didn’t hesitate, because I had no options left,” Mr. Ludwig told The Inquirer in 2015. “And also, these people at Penn had been so wonderful to me and my family for 10 years. I felt obligated to say yes. Did I ever think it would be successful? Not in a million years.”